Page last updated: 2024-08-18

pyrroles and Primary Myelofibrosis

pyrroles has been researched along with Primary Myelofibrosis in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Damsky, W; King, B; Peterson, D1
Apostolidou, E; Borthakur, G; Burger, I; Kantarjian, H; Thomas, D; Verstovsek, S1
Asatiani, E; El-Shami, K; Kantarjian, H; Parikh, SA; Schimmer, A; Verstovsek, S; Walsh, W; Winton, E1
Heinzl, S1
Hasselbalch, HC1
KIMBER, RJ; LANDER, H; ROBSON, HN1

Reviews

1 review(s) available for pyrroles and Primary Myelofibrosis

ArticleYear
[Janus kinase inhibitors as a new therapeutic principle].
    Medizinische Monatsschrift fur Pharmazeuten, 2012, Volume: 35, Issue:10

    Topics: Arthritis, Rheumatoid; Colitis, Ulcerative; Enzyme Inhibitors; Humans; Janus Kinases; Nitriles; Piperidines; Primary Myelofibrosis; Pyrazoles; Pyrimidines; Pyrroles; Signal Transduction

2012

Trials

2 trial(s) available for pyrroles and Primary Myelofibrosis

ArticleYear
Phase II study of sunitinib in patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis.
    Clinical lymphoma, myeloma & leukemia, 2010, Volume: 10, Issue:4

    Topics: Aged; Antineoplastic Agents; Female; Humans; Indoles; Male; Middle Aged; Polycythemia Vera; Primary Myelofibrosis; Pyrroles; Sunitinib; Thrombocythemia, Essential

2010
Phase II study of obatoclax mesylate (GX15-070), a small-molecule BCL-2 family antagonist, for patients with myelofibrosis.
    Clinical lymphoma, myeloma & leukemia, 2010, Volume: 10, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Indoles; Male; Middle Aged; Primary Myelofibrosis; Proto-Oncogene Proteins c-bcl-2; Pyrroles

2010

Other Studies

3 other study(ies) available for pyrroles and Primary Myelofibrosis

ArticleYear
The use of Janus kinase inhibitors in the time of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
    Journal of the American Academy of Dermatology, 2020, Volume: 82, Issue:6

    Topics: Arthritis, Rheumatoid; Azetidines; Betacoronavirus; Colitis, Ulcerative; Coronavirus Infections; COVID-19; Cytokines; Dermatitis, Atopic; Heterocyclic Compounds, 3-Ring; Humans; Immunomodulation; Janus Kinases; Nitriles; Pandemics; Piperidines; Pneumonia, Viral; Primary Myelofibrosis; Purines; Pyrazoles; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; SARS-CoV-2; STAT Transcription Factors; Sulfonamides

2020
SU6668 in idiopathic myelofibrosis--a rational therapeutic approach targeting several tyrosine kinases of importance for the myeloproliferation and the development of bone marrow fibrosis and angiogenesis.
    Medical hypotheses, 2003, Volume: 61, Issue:2

    Topics: Bone Marrow; Enzyme Inhibitors; Humans; Indoles; Models, Biological; Neovascularization, Pathologic; Oxindoles; Primary Myelofibrosis; Propionates; Pyrroles; Receptor Protein-Tyrosine Kinases

2003
THE SEQUESTRATION OF NEM-TREATED RED CELLS IN NORMAL AND ABNORMAL SUBJECTS: A TEST OF SPLENIC UPTAKE FUNCTION.
    The Journal of laboratory and clinical medicine, 1965, Volume: 65

    Topics: Anemia; Anemia, Hemolytic; Erythrocytes; Ethylmaleimide; Hodgkin Disease; Humans; Liver; Liver Cirrhosis; Pharmacology; Physiology; Prednisolone; Primary Myelofibrosis; Pyrroles; Spleen; Splenectomy; Splenomegaly

1965